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Introduction
Although smoking is widely known to be hazardous
to health, there are still many gaps in our knowledge
of its health effects. Firstly, there are gaps in the
scientific knowledge, and more research is needed to
fill these gaps. Secondly, there is a question about how
much scientific knowledge is known by medical and
health professionals, and in the general public. Thirdly,
the tobacco industry and its agents, including scientists
and advertising agencies, continue to deny the health
evidence and portray smoking as a fashionable and
desirable habit. They promote smoking aggressively
to young people and women, especially in China and
other developing countries. While smoking is the single
most preventable cause of death, the multinational
tobacco companies are also the single most powerful
advocates against tobacco control.
This paper is a brief review of the health hazards of
smoking, including passive smoking, with special
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This paper briefly reviews the health hazards associated with smoking, including passive smoking, with
specific reference to local (Hong Kong) evidence. A Medline search of Hong Kong papers from January
1966 to January 1998 was made, and these and other relevant papers were reviewed. In Hong Kong, at
least 10 people die daily from smoking-related diseases. Local studies show that smoking is associated
with lung cancer, oesophageal cancer, liver cancer, ischaemic heart disease, peripheral vascular disease,
ischaemic stroke, peptic ulcer, osteoporosis, impaired lung function, respiratory symptoms, and other
adverse health effects. Smoking in pregnant women can result in smaller babies being born. Pooled
results from four case-control studies show a 60% excess risk of lung cancer due to exposure to
environmental tobacco smoke. Several studies confirm the link between exposure to environmental tobacco
smoke and respiratory illness, hospitalisation, and asthma in children. The risks of smoking (one of every
two smokers will be killed by tobacco) are not well known and are underestimated by both doctors and
the public. Stronger health messages and more local evidence are needed to support tobacco control in
Hong Kong.
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reference to local (Hong Kong) evidence. A discussion
of the problems of how the knowledge can be better
used to prevent the tobacco epidemic in Hong Kong is
also included.
Tobacco and associated deaths
The World Health Organization (WHO), based on
current patterns of consumption, predicts that more
than 500 million people currently alive will be killed
by tobacco. In developed countries, about 20% of all
deaths at present are due to tobacco. By 2020, tobacco
use will cause more than 12% of all deaths globally,
which is higher than the combined percentages of
deaths from infection with the human immuno-
deficiency virus, tuberculosis, maternal mortality,
motor vehicle accidents, suicide, and homicide. On
average, smokers who begin smoking in adolescence
and continue to smoke regularly, have a 50% chance
of dying from the habit. Tobacco kills nearly 10 000
people every day, amounting to 3.5 million deaths
annually.1 How much does Hong Kong contribute to
this death toll?
The first estimate of the total number of deaths
attributable to smoking in Hong Kong appeared in the
1991 to 1992 Department of Health Annual Report,
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which states that “Smoking was estimated to be
responsible for about 3500 lives lost annually.”2 This
constituted approximately 12% of the registered deaths
in 1991. It was also the first time that smoking was
mentioned as “the single most important risk factor,
accounting for 90% of the lung cancer deaths of men
and more than 30% of all cancer deaths.” The estimate
was referred to as “about 3700” in the 1992 to 1993
report3 and “at least 3700” in the 1993 to 1994 report.4
No estimate was mentioned in the 1994 to 1995 and
1995 to 1996 reports.5,6 In a speech given to the
Legislative Council on 15 January 1997, the Secretary
for Health and Welfare stated that up to HK$4 billion
in medical bills and lost productivity, and approxi-
mately 4600 deaths per year were due to smoking.7
Although the methods of estimation were not described,
we understand that they were calculated by multiplying
the total number of deaths due to each disease by the
percentage attributed to smoking, the latter figure
being based on WHO estimates. Another estimate that
includes detailed calculations based on risk estimates
from the United States has been reported by Tsang.8 A
total of 5682 (18.8%) of 30 222 deaths in 1993 were
attributed to smoking: 4987 (29.4%) of 16 987 deaths
in men, and 695 (5.3%) of 13 231 deaths in women.
The direct health costs were estimated to amount to
HK$670 to 970 million annually.
Because these estimates are not based on local data
of risks, the Tobacco Institute challenged the govern-
ment estimates, saying that they represented “nothing
more than the result of an exercise in mathematical
speculation.”9 While we are collecting local data in the
Hong Kong death registries, it is reasonable at present
to accept a conservative estimate (based on WHO
methodology) that at least 10 people are killed by
tobacco each day and Hong Kong contributes 0.1% to
the global tobacco death toll.
Hong Kong studies of the effects of smoking
Local Hong Kong studies that have been published
internationally (based on a Medline search from January
1966 to January 1998; unpublished reports were not
included) show that smoking is associated with lung
cancer,10 oesophageal cancer,11 liver cancer (hepatitis B
surface antigen–negative cases),12 ischaemic heart
disease,13 poorer outcome after recovery from myocardial
infarction,14 peripheral vascular disease,15 Buerger’s
disease,16 cardiac arrhythmia,17 ischaemic stroke,18 peptic
ulcer,19 multiple duodenal ulcer,20 poorer duodenal ulcer
healing rates,21 upper gastro-intestinal haemorrhage,22
osteoporosis,23 impaired ventilatory function24 and
diffusing capacity of the lungs,25 and respiratory
symptoms.26 A hospital-based case-control study
design was used in most studies and, unfortunately, no
large prospective study that focused on smoking and
was of a sufficiently long duration (more than 10 years)
of follow-up has been performed. Because of
methodological problems, such as unrepresentativeness
of the sample, small sample size, potential bias in data
collection, and failure to adjust for confounding factors,
the associations observed in Hong Kong cannot be
considered as definitive proof of causation in the local
context.
All the Hong Kong results, however, corroborate
results from elsewhere and they add to the total body of
evidence about the many known health hazards of
smoking in the literature. Hence, unless proven otherwise,
we can conclude that smoking does cause the same
diseases in Hong Kong as occur in many other countries.
But there are no precise estimates of the magnitude of
the risks and the number of cases attributable to smoking.
Although in Hong Kong, few pregnant women
smoke, one case-control study showed that in those
who did, on average, the babies born were smaller
by 200 g and shorter by 1 cm, and had a head circum-
ference that was smaller by 0.3 cm. These results are
very similar to those obtained elsewhere, even though
the prevalence of smoking among Chinese parturients
is low (2% in this study).27 With the rising prevalence
of smoking in young women in Hong Kong and in
the region, results from such local studies should be
more widely publicised.
Passive smoking
Passive smoking, even if it does not cause cancer, is a
nuisance—a factor which gives strong grounds for its
control (as with other nuisances such as noise, vulgar
language, and indecent exposure). Smoking is a
nuisance not only because of the smell and dirt (ash) it
creates, but also because burn injury can result from
the accidental contact of the skin of a non-smoker with
the burning end of a cigarette of a smoker. In addition,
smoking is a fire hazard.
It is common for people to experience eye, nose, or
throat irritation from the secondhand smoke; some
people also get headaches after inhaling the smoke.
Before the first studies on lung cancer and passive
smoking were reported in 1981,28,29 earlier studies had
shown that passive smoking is harmful to children’s
respiratory health. But these reports did not attract as
much attention as the relationship between passive
smoking and lung cancer.
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In 1986, the United States Surgeon General30 and
the National Research Council31 reviewed all the
available evidence independently and concluded that
passive smoking can cause lung cancer in adult non-
smokers and respiratory illness in children. The same
conclusions were reached by the Independent Scientific
Committee on Smoking and Health in the United
Kingdom in 1988.32 Inhaling other people’s cigarette
smoke constitutes exposure to environmental tobacco
smoke (ETS), which consists of mainstream smoke
(15%), which is exhaled by the smoker and sidestream
smoke (85%), which is released from the burning
cigarette. The concentrations of some carcinogens are
higher in sidestream than in mainstream smoke.30
The most comprehensive review of the effects of
passive smoking is the 1992 report of the United States
Environmental Protection Agency (EPA), which con-
cluded that ETS causes lung cancer in adults and
respiratory illness in children, and also classified ETS
as a Class A human carcinogen.33 Whether or not ETS
can cause coronary heart disease (CHD) was not exam-
ined in the EPA report, but several reviews conclude
that ETS can cause CHD.34-36 In 1997, a review by the
California EPA confirmed previous findings and further
concluded that ETS can cause CHD in non-smokers,
bearing an excess risk of approximately 30%.37
In the same year, two meta-analyses were published
in the British Medical Journal. The first, by Hackshaw
et al,38 reviewed 37 epidemiological studies of women
and nine of men, and announced that “A woman who
has never smoked has an estimated 24% greater risk
of lung cancer if she lives with a smoker.” The second,
by Law et al,39 reviewed 19 epidemiological studies
and concluded that the excess risk of CHD due to ETS,
after adjusting for diet, was 23%. The most recent
report about ETS is the report of the Scientific
Committee on Tobacco and Health from the United
Kingdom,40 which concludes that ETS causes lung
cancer (excess risk 20%-30%), ischaemic heart disease,
serious respiratory illness and asthmatic attacks in
infants and children, sudden infant death syndrome,
and middle ear disease.
Passive smoking in Hong Kong
What evidence do we have about the health hazards
due to ETS in Hong Kong? From 1982 to 1987, four
case-control studies of women who had never smoked,
which included a total of 429 lung cancer patients and
754 controls, were published and included in the 1992
United States EPA report, which calculated that the
excess risk from the Hong Kong studies was about
60%.33 In the review of Hackshaw et al,38 eight studies
in mainland China and four in Hong Kong were as-
sessed; the excess risk was 22%. Not surprisingly,
reviews that are directly or indirectly funded by the to-
bacco industry continue to refute these conclusions.41,42
Good evidence about ETS and CHD in Hong Kong
has not yet been obtained, but we have much evidence
that ETS can cause respiratory illness in children. We
have found respiratory symptoms in primary43,44 and
junior secondary45 level schoolchildren to be associated
with ETS exposure. For instance, the excess risks of
cough and phlegm in secondary level schoolchildren
increased from 19% for exposure to one smoker at
home to 85% for exposure to three or more smokers
(ie a dose-response relationship).45 The excess risk due
to ETS is greater than that due to ambient air
pollution.44,46 We have also found ETS exposure to be
associated with hospitalisation due to respiratory
illnesses in children, the excess risk being 50% with a
dose-response relationship.47 Two studies by other
researchers48,49 suggest that ETS is associated with
asthma in children. In adults, non-smoking women
exposed to ETS have an excess risk of respiratory
symptoms of 20% to 80%.50 A public opinion telephone
survey conducted by our department shows that more
than half of the Hong Kong population often or
sometimes experience symptoms due to ETS exposure
in restaurants.51
We have sufficient evidence in Hong Kong to
support stronger control measures on ETS, and such
evidence should motivate doctors and other health
professionals to join the battle against tobacco. At the
least, we expect doctors and nurses to take every
opportunity to educate their patients. Unfortunately,
Hong Kong doctors do not want to spend time talking
to patients about the effects of smoking, not to mention
passive smoking.
The health effects of smoking
The big risks related to smoking are not well known to
many Hong Kong doctors. In a survey of approximately
40 government doctors who attended a smoking
cessation seminar in December 1995, 56% agreed with
an incorrectly phrased statement that “About 1 out of
20 (ie 5%) smokers, if they continue to smoke, will
eventually be killed by smoking” (the correct answer
is one of every two smokers or 50%); a further 20%
did not know the answer. The corresponding figures
for a survey of 29 government dentists attending a
seminar on smoking were 38% and 28%, respectively.
These results strongly suggest that most doctors tend
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to grossly underestimate the magnitude of risk
associated with smoking (from 50% down to 5%) or
are uncertain about the main risks. A post-seminar
survey was performed 2 to 3 months afterwards and
there were substantial improvements (unpublished
data, 1996).
The gaps in the knowledge of both doctors and the
public can be easily filled, if an individual recognises
the gaps and acts to fill them. The next step is to use
this knowledge to help oneself and others. Those who
are really interested in preventive medicine, health
promotion, and the well-being of their patients and
children need to know a simple fact: the risk of death
due to smoking is huge—one in two.52 If you are a
parent with two smoking teenage children, one of them
will be killed by tobacco if they continue to smoke. If
both of your parents smoke, one of them will die
prematurely because they smoke. If you are a doctor
with four patients who have been smoking regularly,
one will be killed before 70 years of age (losing
approximately 22 years of normal life expectancy) and
another will be killed when older. If you are the family
doctor of these patients, you will lose many years of
business from them when they are hit by serious
smoking-related diseases and admitted to hospitals,
from which they will not return.
The health message needs to be simple, forceful,
and targeted. If a doctor is talking to a smoking patient,
the “one in two” message should be told. We have
carried out a randomised controlled trial in government
out-patient departments and the results show that even
brief advice is effective in motivating patients to quit
smoking. Compared with the 1% sustained abstinence
after a 1-year follow-up, those who are given a booklet
and brief advice have a higher abstinence rate of 5%.53
Greater individual effort is needed for greater success.
An organised campaign is urgently needed to control
the public health harm of tobacco. The creation of a
smoke-free environment will provide not only an
environment that encourages smokers to quit but also
the social climate needed to discourage children and
women from starting the habit. Doctors and health
professionals should actively support and lobby for
stronger government action such as raising the tobacco
tax, banning all forms of tobacco promotion, and
prohibiting smoking in public places including
restaurants, workplaces, and country parks.
Tobacco control policy, health education cam-
paigns, and other interventions need evaluation studies.
Public opinion surveys are important and should be
regularly carried out. Studies are needed to monitor
the pattern and trend of smoking, especially in children
and women. Studies investigating the adverse health
effects of smoking locally and in other parts of China
will provide more and stronger evidence that would
attract media attention and contribute to our knowledge
about smoking in Chinese populations. The tobacco
industry will continue to deny the health evidence and
to argue that smoking is less harmful in Chinese or
other populations when local data are not available.
This is particularly important in Asia because the rise
in smoking prevalence and cigarette consumption is
more recent and there will be a delay of a few decades
before the peak of tobacco-related mortality occurs.
We are now seeing only the beginning of a growing
tobacco epidemic in China, and risk estimates observed
here may appear lower than those in developed
countries, such as the United States and the United
Kingdom, where smoking was widespread during the
1940s and 1950s.54
Conclusion
We know a lot about the health hazards of smoking
and passive smoking but we may have underestimated
the risks. We certainly have not done enough to apply
our knowledge in preventive medicine, particularly in
helping patients and the public to fight against smoking
and passive smoking. Hong Kong has contributed
substantially to the international literature but we have
not successfully carried out large-scale prospective
studies with a long duration of follow-up. The first
Hong Kong Public Health Report in 1994 set some
targets about tobacco control.55 It is time to review how
far we are from the targets set then, before we proceed
into the next millennium.
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